Search clinical trials for: Raloxifene plus cholecalciferol

Total 5997 results

Yonsei University

Completed

Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With Osteopenia

Postemenopusal Women With Osteopenia

Korea, Republic of
Alvogen Korea

Completed

A Drug-drug Interaction Study of DP-R213

Healthy

Korea, Republic of
Addpharma Inc.

Completed

Evaluating the Pharmacokinetic Characteristics of AD-102 in Healthy Volunteers

Osteoporosis

Korea, Republic of
Eli Lilly and Company

Completed

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

Osteoporosis, Postmenopausal

Spain, United States, Taiwan, Italy, Argentina, Canada, France, Australia
Alvogen Korea

Completed

DP-R213 Pharmacokinetics Study

Healthy
Alvogen Korea

Completed

DP-R213 Phase 1 Pharmacokinetics Study

Healthy
Taichung Veterans General Hospital

Unknown

Osteoporosis Treatment in Post-menopausal Women

Depressive Syndrome

Taiwan
Wayne State University
Novartis

Unknown

Vitamin D Augmentation of Tekturna (Aliskiren) in Hypertension (VDATH)

Hypertension

United States
International Centre for Diarrhoeal Disease Research...
Karolinska Institutet; University of Iceland; National Institute of Diseases...

Completed

Clinical Trial of Phenylbutyrate and Vitamin D in Tuberculosis (TB)

Pulmonary Tuberculosis

Bangladesh
University of Nebraska

Completed

Serum 25-hydroxy Vitamin D [25(OH)D] Levels, Supplemental Vitamin D, and Parathyroid Hormone Levels in Premature Infants

Premature Infants

United States
Amsterdam UMC, location VUmc
Radboud University Medical Center; Leiden University Medical Center

Completed

Vitamin D Supplementation in Patients With COPD (PRECOVID)

Chronic Obstructive Pulmonary Disease

Netherlands
Eli Lilly and Company

Completed

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

Breast Cancer | Ovarian Cancer | Endometrial Cancer

United States
Eli Lilly and Company

Completed

Effects of Arzoxifene on Bone Mass and the Uterus

Postmenopausal Bone Loss

United States
National Institute on Aging (NIA)

Completed

AFTER: Altering Fat Through Estrogen and Raloxifene

Postmenopause

United States
Fundació Sant Joan de Déu
Stanley Medical Research Institute; Parc Sanitari Sant Joan de Déu; Hospital...

Completed

Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women

Schizophrenia in Post Menopausal Women

Spain
Faculty Hospital Kralovske Vinohrady
Brno University Hospital; Nemocnice T.Bati, Zlin

Unknown

Vitamin D Substitution During Winter Time

Vitamin D Substitution

Czech Republic
Eli Lilly and Company

Completed

Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

Osteoporosis, Postmenopausal

United States
University Hospital, Saarland

Completed

Evaluation of Colecalciferol Substitution in Dialysis Patients

Hyperparathyroidism, Secondary | RENAL INSUFFICIENCY, CHRONIC

Germany
Federal University of Rio Grande do Sul

Completed

Vitamin D Status After Single Oral Dose of Cholecalciferol in Low Fat Meal Compared to High-fat Meal (VITDAB_08606)

Deficiency, Vitamin D

Brazil
Eli Lilly and Company

Completed

A Study of Arzoxifene to Treat Korean Women With Osteoporosis

Osteoporosis

Korea, Republic of
Germans Trias i Pujol Hospital
Fundació Institut Germans Trias i Pujol; Spanish Clinical Research Network... and other collaborators

Completed

Biological Effect of Vitamin D in Patients With Urothelial Carcinoma (VitDURO)

Urothelial Carcinoma

Spain
Mansoura University

Completed

Effect of Anti-inflammatory and Anti-microbial Co-supplementations in Traumatic ICU Patients at High Risk of Sepsis (DrNoha-ICU)

Sepsis | Major Trauma

Egypt
Radboud University Medical Center

Unknown

The Prevalence of Vitamin D Deficiency and Effects of Vitamin D Supplementation in HIV-1 Infected Patients

HIV Infections | Vitamin D Deficiency

Netherlands
Iris Sommer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Ziekenhuis... and other collaborators

Completed

Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder (RAPSODI)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychosis NOS

Netherlands
Eli Lilly and Company

Completed

Raloxifene Use for The Heart

Cardiovascular Diseases | Breast Neoplasms

United States
University of Wisconsin, Madison
National Institute on Aging (NIA)

Completed

Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease

Alzheimer Disease

United States
Eli Lilly and Company

Completed

Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer

Endometrial Cancer

United States
Chonbuk National University Hospital

Completed

Efficacy and Safety of Catechin High Contain Greentea Extract on Improvement of Cognitive Function

Cognitive Function

Korea, Republic of
The Alfred
National Health and Medical Research Council, Australia; Stanley Medical Research...

Completed

Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia (SERM)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Australia
Toshihiko Kono

Unknown

The Effects of Seasonal Changes in Osteoporosis Treatment

Selective Estrogen Receptor Modulator (SERM)

Japan
Northwestern University
National Cancer Institute (NCI)

Completed

Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer

Endometrial Cancer

United States
Fundació Sant Joan de Déu

Completed

Double Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal Women

Schizophrenia

Spain
Pfizer

Completed

Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)

Osteoporosis, Postmenopausal
The Alfred
Monash University

Completed

Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia

Schizophrenia | Schizoaffective Disorder

Australia
Tuen Mun Hospital
Eli Lilly and Company

Completed

Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy

Osteoporosis

China
Eli Lilly and Company

Completed

Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Metastatic Refractory Ovarian Cancer or Primary Peritoneal Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States
Queen Mary University of London

Completed

Does Vitamin D Supplementation Enhance Resolution of Inflammation After Community-acquired Pneumonia? (ResolveD-CAP)

Pneumonia

United Kingdom
Organon and Co

Completed

Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)

Osteoporosis Postmenopausal
Eunice Kennedy Shriver National Institute of Child...

Completed

The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis

Endometriosis | Pelvic Pain

United States
Hanlim Pharm. Co., Ltd.

Completed

To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women

Osteoporosis

Korea, Republic of
Ligand Pharmaceuticals

Completed

Comparison of Raloxifene and Lasofoxifene - A Randomized, Blinded Study of These Drugs and Placebo on Bone Loss (CORAL)

Osteoporosis

United States
Eli Lilly and Company

Completed

Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis (MORE)

Osteoporosis, Postmenopausal

Singapore, Canada, Mexico, Belgium, France, United States, Argentina, Australia, Austria, Czech Republic, Denmark, Finland, Germany, Hungary, Israel, Italy, Netherlands, New Zealand, Norway, Poland, Slovakia, Slovenia, Spain, Sweden, United...
Eli Lilly and Company

Completed

EVA: Evista Alendronate Comparison

Osteoporosis

United States, Canada
Dompé Farmaceutici S.p.A

Completed

Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.

SARS CoV 2 Infection

France, Spain, Italy
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Hormone Therapy in Treating Women With Breast Cancer

Breast Cancer

United States
Sara Saeidi Shahri

Completed

Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis

Rheumatoid Arthritis
European Institute of Oncology

Terminated

MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients (MelaViD)

Melanoma

Italy
NSABP Foundation Inc
National Cancer Institute (NCI); Eli Lilly and Company; AstraZeneca

Completed

Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women

Breast Cancer

United States, Canada, Puerto Rico
Stanford University
Indiana University; Kaiser Permanente; Southern Illinois University

Completed

Raloxifene for Women With Alzheimer's Disease

Alzheimer Disease

United States
University of Valencia

Completed

Clinical Study of Raloxifene and Strontium Ranelate in Postmenopausal Osteoporosis

Postmenopausal Osteoporosis | Compliance

Spain

Search clinical trials for: Raloxifene plus cholecalciferol

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations